Cargando…

Comprehensive Genomic Profiling of Circulating Cell-Free DNA Distinguishes Focal MET Amplification from Aneuploidy in Diverse Advanced Cancers

Amplification (amp) of MET can be observed in cases of focal gene copy number gain, such as MET-driven amp, or with a gain of chromosome 7, such as aneuploidy. Several studies have shown that only high-level focal MET amp (MET/CEP7 ratio ≥5) is oncogenic, with such tumors responding to targeted ther...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kumaki, Yuichi, Olsen, Steve, Suenaga, Mitsukuni, Nakagawa, Tsuyoshi, Uetake, Hiroyuki, Ikeda, Sadakatsu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8534719/ https://www.ncbi.nlm.nih.gov/pubmed/34677235 http://dx.doi.org/10.3390/curroncol28050317

Ejemplares similares

Targeting MET Amplification: Opportunities and Obstacles in Therapeutic Approaches
por: Kumaki, Yuichi, et al.
Publicado: (2023)

Strategic Insight into the Combination Therapies for Metastatic Colorectal Cancer
por: Kano, Yoshihito, et al.
Publicado: (2023)

MET alterations detected in blood-derived circulating tumor DNA correlate with bone metastases and poor prognosis
por: Ikeda, Sadakatsu, et al.
Publicado: (2018)

Spontaneous regression of breast lymphoproliferative disorders after withdrawal of methotrexate in rheumatoid arthritis patients with Epstein–Barr virus infection: a case report and review of the literature
por: Ogawa, Ayumi, et al.
Publicado: (2022)

A Case of Breast Cancer in a Patient with a Congenital Pectoralis Muscle Defect
por: Nakagawa, Tsuyoshi, et al.
Publicado: (2021)

Clinical utility of comprehensive genomic profiling in Japan: Result of PROFILE-F study
por: Aoyagi, Yasuko, et al.
Publicado: (2022)

Targeting MET Amplification as a New Oncogenic Driver
por: Kawakami, Hisato, et al.
Publicado: (2014)

Pan-cancer analysis distinguishes transcriptional changes of aneuploidy from proliferation
por: Buccitelli, Christopher, et al.
Publicado: (2017)

Laparoscopic Abdominal Surgery after Primary Breast Reconstruction Using an Abdominal Flap
por: Nakagawa, Tsuyoshi, et al.
Publicado: (2021)

Focal Uptake in the Sternum on (18)F-FDG-PET/CT Caused by G-CSF Therapy after Chemotherapy Mimicking Bone Metastasis of Breast Cancer
por: Hayashi, Kumiko, et al.
Publicado: (2022)

Treatment of advanced lung cancer based on genomic profiling using liquid biopsy (plasma): A review of three cases
por: Mitsumura, Takahiro, et al.
Publicado: (2021)

MET amplification as a potential therapeutic target in gastric cancer
por: Kawakami, Hisato, et al.
Publicado: (2012)

Comprehensive Genomic Profiling Reveals Clinical Associations in Response to Immune Therapy in Head and Neck Cancer
por: Noji, Rika, et al.
Publicado: (2022)

Differential roles of trans-phosphorylated EGFR, HER2, HER3, and RET as heterodimerisation partners of MET in lung cancer with MET amplification
por: Tanizaki, J, et al.
Publicado: (2011)

RB acute loss induces centrosome amplification and aneuploidy in murine primary fibroblasts
por: Iovino, Flora, et al.
Publicado: (2006)

Depletion of the oncoprotein Bcl-3 induces centrosome amplification and aneuploidy in cancer cells
por: Zamora, Ruben, et al.
Publicado: (2010)

Emergence of MET hyper-amplification at progression to MET and BRAF inhibition in colorectal cancer
por: Oddo, Daniele, et al.
Publicado: (2017)

MET Amplification and Efficacy of Nivolumab in Patients With NSCLC
por: Yoshimura, Katsuhiro, et al.
Publicado: (2021)

MET amplification identified by next-generation sequencing and its clinical relevance for MET inhibitors
por: Peng, Lun-Xi, et al.
Publicado: (2021)

Correlation of MET-Receptor Overexpression with MET Gene Amplification and Patient Outcome in Malignant Mesothelioma
por: Santoni-Rugiu, Eric, et al.
Publicado: (2021)

MET nucleotide variations and amplification in advanced ovarian cancer: characteristics and outcomes with c-Met inhibitors
por: Tang, Chad, et al.
Publicado: (2013)

A case report of response to crizotinib in chemotherapy-refractory metastatic gallbladder cancer with met amplification and acquired resistance resulting from the loss of MET amplification
por: Sun, Hongna, et al.
Publicado: (2021)

Nuclear Expression of p-STAT3 Is Associated with Poor Prognosis in ER(−) Breast Cancer
por: Nakagawa, Tsuyoshi, et al.
Publicado: (2022)

Anti-c-Met monoclonal antibody ABT-700 breaks oncogene addiction in tumors with MET amplification
por: Wang, Jieyi, et al.
Publicado: (2016)

TP53 mutation and MET amplification in circulating tumor DNA analysis predict disease progression in patients with advanced gastric cancer
por: Li, Jia, et al.
Publicado: (2021)

Modulation of gene expression in drug resistant Leishmania is associated with gene amplification, gene deletion and chromosome aneuploidy
por: Ubeda, Jean-Michel, et al.
Publicado: (2008)

Aberrations in Angiogenic Signaling and MYC Amplifications are Distinguishing Features of Angiosarcoma
por: Kurisetty, Vittal, et al.
Publicado: (2013)

MET Gene Amplification and MET Receptor Activation Are Not Sufficient to Predict Efficacy of Combined MET and EGFR Inhibitors in EGFR TKI-Resistant NSCLC Cells
por: Presutti, Dario, et al.
Publicado: (2015)

MET Inhibitor is Expected to Overcome MET Amplification-Induced Immunotherapy Resistance in Non-Small Cell Lung Cancer
por: Ruan, Ji
Publicado: (2021)

Genomic DNA methylation distinguishes subtypes of human focal cortical dysplasia
por: Kobow, Katja, et al.
Publicado: (2019)

PARP Inhibitor Decreases Akt Phosphorylation and Induces Centrosome Amplification and Chromosomal Aneuploidy in CHO-K1 Cells
por: Tanaka, Masakazu, et al.
Publicado: (2022)

Expression of TIM3/VISTA checkpoints and the CD68 macrophage-associated marker correlates with anti-PD1/PDL1 resistance: implications of immunogram heterogeneity
por: Kato, Shumei, et al.
Publicado: (2020)

Associations between deepness of response and clinical outcomes among Japanese patients with metastatic colorectal cancer treated with second-line FOLFIRI plus cetuximab
por: Osumi, Hiroki, et al.
Publicado: (2015)

Cetuximab could be more effective without prior bevacizumab treatment in metastatic colorectal cancer patients
por: Sato, Yasuyoshi, et al.
Publicado: (2015)

MET overexpression, gene amplification and relevant clinicopathological features in gastric adenocarcinoma
por: Zhang, Jing, et al.
Publicado: (2016)

Optimal Treatments for NSCLC Patients Harboring Primary or Acquired MET Amplification
por: Sun, Dantong, et al.
Publicado: (2022)

Metastatic basal cell carcinoma with amplification of PD-L1: exceptional response to anti-PD1 therapy
por: Ikeda, Sadakatsu, et al.
Publicado: (2016)

Circulating tumor DNA profiling by next generation sequencing reveals heterogeneity of crizotinib resistance mechanisms in a gastric cancer patient with MET amplification
por: Du, Juan, et al.
Publicado: (2017)

Exploring the landscape of focal amplifications in cancer using AmpliconArchitect
por: Deshpande, Viraj, et al.
Publicado: (2019)

The Epigenetic Origin of Aneuploidy
por: Herrera, Luis A, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_8o8sa17dfd5cah12ei4i8a6162